DLBCL, NOS GENETIC SUBTYPES

Clinical trials for DLBCL, NOS GENETIC SUBTYPES explained in plain language.

Never miss a new study

Get alerted when new DLBCL, NOS GENETIC SUBTYPES trials appear

Sign up with your email to follow new studies for DLBCL, NOS GENETIC SUBTYPES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New combo therapy fights back against stubborn blood cancers

Disease control Ongoing

This study is testing if adding the drug acalabrutinib to a personalized cell therapy (liso-cel) is safe and effective for adults with aggressive B-cell lymphomas that have come back or not responded to at least two prior treatments. Participants receive a one-time infusion of th…

Matched conditions: DLBCL, NOS GENETIC SUBTYPES

Phase: PHASE2 • Sponsor: Patrick C. Johnson, MD • Aim: Disease control

Last updated Mar 27, 2026 12:37 UTC

DLBCL, NOS GENETIC SUBTYPES

Get alerted when new DLBCL, NOS GENETIC SUBTYPES trials appear

New combo therapy fights back against stubborn blood cancers